Skip to main content

Volume 4 Supplement 2

Current perspectives on the treatment of rheumatic diseases with infliximab


Edited by Peter E Lipsky and Ravinder N Maini

Supported by an educational grant from Centocor, Inc.

  1. Since the initial characterization of tumor necrosis factor alpha (TNFα), it has become clear that TNFα has diverse biologic activity. The realization that TNFα plays a role in rheumatoid arthritis (RA) has le...

    Authors: Ravinder N Maini and Marc Feldmann
    Citation: Arthritis Research & Therapy 2002 4(Suppl 2):S22

Annual Journal Metrics